• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偏头痛筛查问卷(MS-Q)的新用途:在初级保健环境中的验证和发现隐匿性偏头痛的能力。初级保健中的 MS-Q。

New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care.

机构信息

Department of Neurology, University Hospital of Valencia, Valencia, Spain.

出版信息

BMC Neurol. 2010 Jun 8;10:39. doi: 10.1186/1471-2377-10-39.

DOI:10.1186/1471-2377-10-39
PMID:20529347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2906427/
Abstract

BACKGROUND

PC plays an important role in early diagnosis of health disorders, particularly migraine, due to the financial impact of this disease for the society and its impact on patients' quality of life. The aim of the study was to validate the self-administered MS-Q questionnaire for detection of hidden migraine in the field of primary care (PC), and to explore its use in this setting.

METHODS

Cross-sectional, observational, and multicentre study in subjects above 18 years of age patients attending PC centers (regardless of the reason for consultation). A MS-Q score > or = 4 was considered possible migraine. Level of agreement with IHS criteria clinical diagnosis (kappa coefficient), and instrument's validity properties: sensitivity, specificity, positive (PPV) and negative (NPV) predictive values were determined. The ability of the instrument to identify possible new cases of migraine was calculated, as well as the ratio of hidden disease compared to the ratio obtained by IHS criteria.

RESULTS

A total of 9,670 patients were included [48.9 +/- 17.2 years (mean +/- SD); 61.9% women], from 410 PC centers representative of the whole national territory. The clinical prevalence of migraine according to the IHS criteria was 24.7%, and 20.4% according to MS-Q: Kappa index of agreement 0.82 (p < 0.05). MS-Q sensitivity was 0.82 (95% CI, 0.81-0.84), specificity 0.97 (95% CI, 0.98-0.99), PPV 0.95 (95% CI, 0.94 - 0.96), and NPV 0.94 (95% CI, 0.93-0.95). No statistically significant differences were found in the percentages of patients with de novo and hidden migraine identified by MS-Q and by IHS criteria: 5.7% vs. 6.1% and 26.6% vs. 24.1%, respectively.

CONCLUSIONS

The results of the present study confirm the usefulness of the MS-Q questionnaire for the early detection and assessment of migraine in PC settings, and its ability to detect hidden migraine.

摘要

背景

PC 在健康障碍的早期诊断中起着重要作用,尤其是偏头痛,因为这种疾病对社会的经济影响及其对患者生活质量的影响。本研究的目的是验证自我管理的 MS-Q 问卷在初级保健(PC)领域中用于检测隐匿性偏头痛的有效性,并探讨其在该领域的应用。

方法

横断面、观察性和多中心研究,纳入年龄在 18 岁以上的 PC 中心就诊患者(无论就诊原因如何)。MS-Q 得分为>或= 4 被认为是可能的偏头痛。采用 IHS 标准临床诊断的一致性(kappa 系数)和仪器的有效性特征:灵敏度、特异性、阳性(PPV)和阴性(NPV)预测值进行测定。还计算了仪器识别可能新的偏头痛病例的能力,以及与 IHS 标准获得的隐匿性疾病的比值。

结果

共纳入 9670 例患者[48.9 +/- 17.2 岁(均值 +/- 标准差);61.9%为女性],来自代表全国范围的 410 个 PC 中心。根据 IHS 标准,偏头痛的临床患病率为 24.7%,根据 MS-Q 为 20.4%:一致性的 Kappa 指数为 0.82(p < 0.05)。MS-Q 的灵敏度为 0.82(95%置信区间,0.81-0.84),特异性为 0.97(95%置信区间,0.98-0.99),PPV 为 0.95(95%置信区间,0.94-0.96),NPV 为 0.94(95%置信区间,0.93-0.95)。用 MS-Q 和 IHS 标准识别的新发和隐匿性偏头痛患者的百分比无统计学差异:5.7% vs. 6.1%和 26.6% vs. 24.1%。

结论

本研究结果证实了 MS-Q 问卷在 PC 环境中用于早期检测和评估偏头痛的有效性,以及其检测隐匿性偏头痛的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee06/2906427/fbbea9fb871f/1471-2377-10-39-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee06/2906427/fbbea9fb871f/1471-2377-10-39-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee06/2906427/fbbea9fb871f/1471-2377-10-39-1.jpg

相似文献

1
New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care.偏头痛筛查问卷(MS-Q)的新用途:在初级保健环境中的验证和发现隐匿性偏头痛的能力。初级保健中的 MS-Q。
BMC Neurol. 2010 Jun 8;10:39. doi: 10.1186/1471-2377-10-39.
2
Development and validation of the Migraine Screen Questionnaire (MS-Q).偏头痛筛查问卷(MS-Q)的开发与验证
Headache. 2005 Nov-Dec;45(10):1328-38. doi: 10.1111/j.1526-4610.2005.00265.x.
3
Validation of The 3-Question Headache Screen in The Diagnosis of Migraine in Nigeria.三问题头痛筛查在尼日利亚偏头痛诊断中的验证
Ethiop J Health Sci. 2016 Jan;26(1):5-8. doi: 10.4314/ejhs.v26i1.3.
4
Translation and Transcultural Validation of Migraine Screening Questionnaire (MS-Q).偏头痛筛查问卷(MS-Q)的翻译与跨文化验证
Med Arch. 2018 Dec;72(6):430-433. doi: 10.5455/medarh.2018.72.430-433.
5
Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).基层医疗中偏头痛的识别与管理:头痛影响测试(HIT)所测量的功能影响的作用
Cephalalgia. 2005 Mar;25(3):184-90. doi: 10.1111/j.1468-2982.2004.00820.x.
6
A self-administered screener for migraine in primary care: The ID Migraine validation study.基层医疗中偏头痛的自我管理筛查工具:ID偏头痛验证研究。
Neurology. 2003 Aug 12;61(3):375-82. doi: 10.1212/01.wnl.0000078940.53438.83.
7
Headache in patients with inflammatory bowel disease: Migraine prevalence according to the Migraine Screening-Questionnaire (MS-Q) and headache characteristics.炎症性肠病患者的头痛:偏头痛患病率的偏头痛筛查问卷(MS-Q)和头痛特征。
Gastroenterol Hepatol. 2024 Jan;47(1):63-71. doi: 10.1016/j.gastrohep.2023.05.001. Epub 2023 May 5.
8
Are doctors accurate when diagnosing themselves with migraine? A study on migraine prevalence among doctors in a tertiary care hospital.医生在自我诊断偏头痛时准确吗?一家三级医院医生偏头痛患病率的研究。
Acta Neurol Belg. 2021 Aug;121(4):1045-1051. doi: 10.1007/s13760-021-01727-w. Epub 2021 Jul 3.
9
A validation study of an Italian version of the ID Migraine: preliminary results.意大利版ID偏头痛的验证研究:初步结果。
J Headache Pain. 2005 Sep;6(4):216-9. doi: 10.1007/s10194-005-0189-7.
10
Migraine in adolescents: validation of a screening questionnaire.青少年偏头痛:一份筛查问卷的验证
Headache. 2009 Feb;49(2):202-11. doi: 10.1111/j.1526-4610.2008.01261.x.

引用本文的文献

1
Prevalence, Factors and Impact of Migraine on Healthcare Professionals: .偏头痛在医疗保健专业人员中的患病率、影响因素及影响
Sultan Qaboos Univ Med J. 2025 May 2;25(1):409-417. doi: 10.18295/2075-0528.2851.
2
Migraine headache and other risk factors associated with glaucoma among the adult population living in Armenia: a case-control study.亚美尼亚成年人偏头痛和其他与青光眼相关的风险因素:病例对照研究。
Int Ophthalmol. 2024 Apr 22;44(1):188. doi: 10.1007/s10792-024-03145-2.
3
Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review.

本文引用的文献

1
Migraine prevalence, disease burden, and the need for preventive therapy.偏头痛的患病率、疾病负担及预防性治疗的必要性。
Neurology. 2007 Jan 30;68(5):343-9. doi: 10.1212/01.wnl.0000252808.97649.21.
2
Psychiatric comorbidity of migraine.偏头痛的精神共病
Headache. 2006 Oct;46(9):1327-33. doi: 10.1111/j.1526-4610.2006.00576.x.
3
[Attitudes of spanish primary care doctors to migraine].[西班牙初级保健医生对偏头痛的态度]
偏头痛伴有急性药物过度使用或精神共病的负担,以及 CGRP 通路靶向单克隆抗体的治疗:综述。
Medicine (Baltimore). 2023 Jun 9;102(23):e33874. doi: 10.1097/MD.0000000000033874.
4
The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization.临床量表和患者报告结局量表在头痛疾病和偏头痛中的应用,总结其传播和实施情况。
Heliyon. 2023 May 13;9(5):e16187. doi: 10.1016/j.heliyon.2023.e16187. eCollection 2023 May.
5
Measuring the susceptibility to visually induced motion sickness and its relationship with vertigo, dizziness, migraine, syncope and personality traits.测量视觉诱发运动病的易感性及其与眩晕、头晕、偏头痛、晕厥和人格特质的关系。
Exp Brain Res. 2023 May;241(5):1381-1391. doi: 10.1007/s00221-023-06603-y. Epub 2023 Apr 5.
6
Validation studies on migraine diagnostic tools for use in nonclinical settings: a systematic review.用于非临床环境的偏头痛诊断工具的验证研究:系统评价。
Arq Neuropsiquiatr. 2023 Apr;81(4):399-412. doi: 10.1055/s-0042-1756490. Epub 2022 Oct 27.
7
Association of Migraine and Irritable Bowel Syndrome in Saudi Arabia: A Nationwide Survey.沙特阿拉伯偏头痛与肠易激综合征的关联:一项全国性调查。
Biomed Res Int. 2022 Jan 18;2022:8690562. doi: 10.1155/2022/8690562. eCollection 2022.
8
The Visually Induced Motion Sickness Susceptibility Questionnaire (VIMSSQ): Estimating Individual Susceptibility to Motion Sickness-Like Symptoms When Using Visual Devices.视诱导运动病易感性问卷(VIMSSQ):评估使用视觉设备时出现运动病样症状的个体易感性。
Hum Factors. 2023 Feb;65(1):107-124. doi: 10.1177/00187208211008687. Epub 2021 Apr 19.
9
Migraine screen questionnaire: further psychometric evidence from categorical data methods.偏头痛筛查问卷:来自分类数据方法的进一步心理测量学证据。
Health Qual Life Outcomes. 2020 Apr 28;18(1):113. doi: 10.1186/s12955-020-01361-9.
10
Factors associated with delayed diagnosis of migraine: A hospital-based cross-sectional study.偏头痛延迟诊断的相关因素:一项基于医院的横断面研究。
J Family Med Prim Care. 2019 Jun;8(6):1925-1930. doi: 10.4103/jfmpc.jfmpc_376_19.
Aten Primaria. 2006 Jun 15;38(1):33-8. doi: 10.1157/13090029.
4
Prevalence, burden, and cost of headache disorders.头痛疾病的患病率、负担及成本
Curr Opin Neurol. 2006 Jun;19(3):281-5. doi: 10.1097/01.wco.0000227039.16071.92.
5
Risk-benefit and cost-benefit ratio in headache treatment.头痛治疗中的风险效益与成本效益比。
J Headache Pain. 2005 Sep;6(4):315-8. doi: 10.1007/s10194-005-0219-5.
6
Development and validation of the Migraine Screen Questionnaire (MS-Q).偏头痛筛查问卷(MS-Q)的开发与验证
Headache. 2005 Nov-Dec;45(10):1328-38. doi: 10.1111/j.1526-4610.2005.00265.x.
7
Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management.与偏头痛相关的焦虑和抑郁:对偏头痛患者残疾状况和生活质量的影响以及偏头痛急性发作的管理。
Pain. 2005 Dec 5;118(3):319-326. doi: 10.1016/j.pain.2005.09.010. Epub 2005 Nov 14.
8
Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).基层医疗中偏头痛的识别与管理:头痛影响测试(HIT)所测量的功能影响的作用
Cephalalgia. 2005 Mar;25(3):184-90. doi: 10.1111/j.1468-2982.2004.00820.x.
9
The burden of migraine in Spain: beyond direct costs.西班牙偏头痛的负担:超出直接成本
Pharmacoeconomics. 2004;22(9):591-603. doi: 10.2165/00019053-200422090-00004.
10
Common headache misdiagnoses.常见的头痛误诊。
Prim Care. 2004 Jun;31(2):395-405, viii. doi: 10.1016/j.pop.2004.02.010.